BRTX · Company research
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| BioRestorative Therapies (BRTX) Closes Flat at $2.33 as Range Holds Between Key Levels - Stop Loss Guidance - siam.in | BioRestorative Therapies (BRTX) Closes Flat at $2.33 as Range Holds Between Key Levels - Stop Loss Guidance siam.in | View source ↗ | siam.in | Oct 1, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies (BRTX) Closes Flat at $2.33 as Range Holds Between Key Levels - Low Beta Factor - https://www.dars.gov.et/ | BioRestorative Therapies (BRTX) Closes Flat at $2.33 as Range Holds Between Key Levels - Low Beta Factor https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 1, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies Faces Nasdaq Delinquency Notice Risk - The Globe and Mail | BioRestorative Therapies Faces Nasdaq Delinquency Notice Risk The Globe and Mail | View source ↗ | The Globe and Mail | Aug 26, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies Received Notice of Noncompliance - TradingView | BioRestorative Therapies Received Notice of Noncompliance TradingView | View source ↗ | TradingView | Aug 25, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan | BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk Stock Titan | View source ↗ | Stock Titan | Aug 14, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies Announces Completion of BRTX-100 Manufacturing for Phase 2 Clinical Trial - Quiver Quantitative | BioRestorative Therapies Announces Completion of BRTX-100 Manufacturing for Phase 2 Clinical Trial Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 25, 2026 | neutral | 0 | 0.6 |
| Which stocks have an unusual volume on Thursday? - ChartMill | Which stocks have an unusual volume on Thursday? ChartMill | View source ↗ | ChartMill | May 28, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies Completes Patient Dosing in Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - Quiver Quantitative | BioRestorative Therapies Completes Patient Dosing in Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease Quiver Quantitative | View source ↗ | Quiver Quantitative | May 26, 2026 | neutral | 0 | 0.6 |
| Stem cell back pain shot finishes Phase 2, topline data due 2027 - Stock Titan | Stem cell back pain shot finishes Phase 2, topline data due 2027 Stock Titan | View source ↗ | Stock Titan | May 26, 2026 | neutral | 0 | 0.6 |
| What Makes Biorestorative Therapies (BRTX) a New Buy Stock - Yahoo Finance | What Makes Biorestorative Therapies (BRTX) a New Buy Stock Yahoo Finance | View source ↗ | Yahoo Finance | May 15, 2026 | neutral | 0 | 0.6 |
| Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance | Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | May 14, 2026 | neutral | 0 | 0.6 |
| Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing - Yahoo Finance | Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing Yahoo Finance | View source ↗ | Yahoo Finance | Apr 27, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies stock plunges after $5 million public offering - Investing.com | BioRestorative Therapies stock plunges after $5 million public offering Investing.com | View source ↗ | Investing.com | Feb 12, 2026 | neutral | 0 | 0.6 |
| BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook - Simply Wall Street | BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook Simply Wall Street | View source ↗ | Simply Wall Street | Nov 5, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 5, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.